EM49, a new peptide antibiotic. I. Fermentation, isolation, and preliminary characterization.
D000900:Anti-Bacterial Agents / Q000302:isolation & purification* / Q000494:pharmacology; D000935:Antifungal Agents / Q000302:isolation & purification; D000981:Antiprotozoal Agents / Q000302:isolation & purification; D001407:Bacillus / Q000032:analysis; D001412:Bacillus subtilis / Q000187:drug effects; D002176:Candida albicans / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D002854:Chromatography, Paper; D004926:Escherichia coli / Q000187:drug effects; D005227:Fatty Acids / Q000302:isolation & purification / Q000494:pharmacology; D005285:Fermentation; D008970:Molecular Weight; D010456:Peptides, Cyclic / Q000302:isolation & purification* / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012706:Serratia marcescens / Q000187:drug effects; D013055:Spectrophotometry, Infrared; D013210:Staphylococcus / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D014246:Trichomonas vaginalis / Q000187:drug effects; D014249:Trichophyton / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D005227:Fatty Acids; D010456:Peptides, Cyclic